PREDICTING THE ROLE OF THE PRETREATMENT NEUTROPHIL TO LYMPHOCYTE RATIO IN THE SURVIVAL OF RECURRENT GLIOBLASTOMA MULTIFORME PATIENTS TREATED WITH BEVACIZUMAB AND IRINOTECAN

BOZKURT O., İNANÇ M.

2 nd International Congress on Oncological Sciences, 20 - 23 Eylül 2018, (Özet Bildiri)

• Yayın Türü: Bildiri / Özet Bildiri
• Erciyes Üniversitesi Adresli: Evet